H2BC26
gene geneOn this page
Summary
H2BC26 (H2B clustered histone 26, HGNC:20514) is a protein-coding gene on chromosome 1q42.13, encoding Histone H2B type 3-B (Q8N257). Core component of nucleosome.
Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H2B family. Transcripts from this gene contain a palindromic termination element.
Source: NCBI Gene 128312 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_175055
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20514 |
| Approved symbol | H2BC26 |
| Name | H2B clustered histone 26 |
| Location | 1q42.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000196890 |
| Ensembl biotype | protein_coding |
| OMIM | 615046 |
| Entrez | 128312 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000620438, ENST00000690378, ENST00000693095
RefSeq mRNA: 1 — MANE Select: NM_175055
NM_175055
CCDS: CCDS1574
Canonical transcript exons
ENST00000647549 — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 119 present calls, max score 76.83.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 63.2815 / max 1825.3523, expressed in 1654 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 8949 | 63.2815 | 1654 |
Top tissues by expression
125 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow cell | CL:0002092 | 76.83 | gold quality |
| right uterine tube | UBERON:0001302 | 71.02 | gold quality |
| cerebellum | UBERON:0002037 | 70.63 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 70.61 | gold quality |
| cerebellar cortex | UBERON:0002129 | 70.58 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 69.91 | gold quality |
| ganglionic eminence | UBERON:0004023 | 66.61 | gold quality |
| ventricular zone | UBERON:0003053 | 63.01 | gold quality |
| bone marrow | UBERON:0002371 | 62.18 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 61.84 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.47 | gold quality |
| prefrontal cortex | UBERON:0000451 | 59.98 | gold quality |
| blood | UBERON:0000178 | 59.61 | gold quality |
| vagina | UBERON:0000996 | 59.28 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 59.08 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 58.66 | gold quality |
| frontal cortex | UBERON:0001870 | 56.94 | gold quality |
| right adrenal gland | UBERON:0001233 | 56.76 | gold quality |
| cortical plate | UBERON:0005343 | 56.48 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 56.32 | gold quality |
| tonsil | UBERON:0002372 | 56.07 | gold quality |
| granulocyte | CL:0000094 | 55.81 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 55.62 | gold quality |
| brain | UBERON:0000955 | 55.53 | gold quality |
| colonic epithelium | UBERON:0000397 | 55.25 | gold quality |
| left adrenal gland | UBERON:0001234 | 55.22 | gold quality |
| skin of abdomen | UBERON:0001416 | 55.21 | gold quality |
| esophagus mucosa | UBERON:0002469 | 55.09 | gold quality |
| adrenal gland | UBERON:0002369 | 55.07 | gold quality |
| nucleus accumbens | UBERON:0001882 | 54.85 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6379 | no | 178.72 |
| E-ANND-3 | no | 0.86 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- Histone H2B represents a regulated plasminogen receptor, which contributes significantly to the plasminogen binding capacity of cells. (PMID:16878981)
- infertile men have a higher proportion of spermatozoa with diffuse histone H2B (PMID:18958350)
- USP7 can stimulate EBNA1-DNA interactions and EBNA1 can alter histone modification at oriP through recruitment of USP7. (PMID:19834552)
- The present findings provide evidence indicating that the extrachromosomal histone H2B is engaged in the signaling pathway initiated by dsDNA to trigger antiviral innate immune responses. (PMID:19906922)
- ATM-dependent monoubiquitylation of histone H2B is required for timely repair of DNA double-strand breaks (PMID:21362549)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | H2bc26 | ENSMUSG00000080712 |
| rattus_norvegicus | H2bu1 | ENSRNOG00000085593 |
Paralogs (21): H2BW2 (ENSG00000101812), H2BW1 (ENSG00000123569), H2BC11 (ENSG00000124635), H2BC1 (ENSG00000146047), H2BC5 (ENSG00000158373), H2BC4 (ENSG00000180596), H2BC21 (ENSG00000184678), H2BC13 (ENSG00000185130), H2BC12 (ENSG00000197903), H2BC18 (ENSG00000203814), H2BC15 (ENSG00000233822), H2BC12L (ENSG00000234289), H2BC14 (ENSG00000273703), H2BC8 (ENSG00000273802), H2BC6 (ENSG00000274290), H2BC17 (ENSG00000274641), H2BC9 (ENSG00000275713), H2BC3 (ENSG00000276410), H2BC7 (ENSG00000277224), H2BC10 (ENSG00000278588), H2BK1 (ENSG00000285480)
Protein
Protein identifiers
Histone H2B type 3-B — Q8N257 (reviewed: Q8N257)
Alternative names: H2B type 12, H2B-clustered histone 26, H2B.U histone 1
All UniProt accessions (1): Q8N257
UniProt curated annotations — full annotation on UniProt →
Function. Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.
Subunit / interactions. The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA.
Subcellular location. Nucleus. Chromosome.
Post-translational modifications. Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is required for histone H3 ‘Lys-4’ (H3K4me) and ‘Lys-79’ (H3K79me) methylation and transcription activation at specific gene loci, such as HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121 (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 ‘Lys-4’ and ‘Lys-79’ methylation. It also functions cooperatively with the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub also acts as a regulator of mRNA splicing: deubiquitination by USP49 is required for efficient cotranscriptional splicing of a large set of exons. Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress promotes transcription. Phosphorylated on Ser-15 (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic chromatin condensation. Also phosphorylated on Ser-15 in response to DNA double strand breaks (DSBs), and in correlation with somatic hypermutation and immunoglobulin class-switch recombination. GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121. It fluctuates in response to extracellular glucose, and associates with transcribed genes. ADP-ribosylated by PARP1 or PARP2 on Ser-7 (H2BS6ADPr) in response to DNA damage. H2BS6ADPr promotes recruitment of CHD1L. Poly ADP-ribosylation on Glu-36 (H2BE35ADPr) by PARP1 regulates adipogenesis: it inhibits phosphorylation at Ser-37 (H2BS36ph), thereby blocking expression of pro-adipogenetic genes. Crotonylation (Kcr) is specifically present in male germ cells and marks testis-specific genes in post-meiotic cells, including X-linked genes that escape sex chromosome inactivation in haploid cells. Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors. It is also associated with post-meiotically activated genes on autosomes. Lactylated in macrophages by EP300/P300 by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription.
Similarity. Belongs to the histone H2B family.
RefSeq proteins (1): NP_778225* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000558 | Histone_H2B | Family |
| IPR007125 | H2A/H2B/H3 | Domain |
| IPR009072 | Histone-fold | Homologous_superfamily |
| IPR055333 | HISTONE_H2B_site | Conserved_site |
Pfam: PF00125
UniProt features (99 total): modified residue 90, cross-link 4, initiator methionine 1, chain 1, region of interest 1, compositionally biased region 1, glycosylation site 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6BIZ | X-RAY DIFFRACTION | 2.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N257-F1 | 87.46 | 0.68 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (94): 6, 6, 6, 7, 12, 12, 12, 12, 12, 12, 13, 13, 13, 15, 16, 16, 16, 16, 17, 17 …
Glycosylation sites (1): 113
Function
Pathways and Gene Ontology
Reactome pathways
57 pathways
| ID | Pathway |
|---|---|
| R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected pyrimidine |
| R-HSA-110329 | Cleavage of the damaged pyrimidine |
| R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected purine |
| R-HSA-110331 | Cleavage of the damaged purine |
| R-HSA-1221632 | Meiotic synapsis |
| R-HSA-171306 | Packaging Of Telomere Ends |
| R-HSA-1912408 | Pre-NOTCH Transcription and Translation |
| R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex |
| R-HSA-212300 | PRC2 methylates histones and DNA |
| R-HSA-2299718 | Condensation of Prophase Chromosomes |
| R-HSA-2559580 | Oxidative Stress Induced Senescence |
| R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) |
| R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence |
| R-HSA-3214815 | HDACs deacetylate histones |
| R-HSA-3214847 | HATs acetylate histones |
| R-HSA-427359 | SIRT1 negatively regulates rRNA expression |
| R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression |
| R-HSA-427413 | NoRC negatively regulates rRNA expression |
| R-HSA-5250924 | B-WICH complex positively regulates rRNA expression |
| R-HSA-5334118 | DNA methylation |
| R-HSA-5578749 | Transcriptional regulation by small RNAs |
| R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis |
| R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 |
| R-HSA-5689880 | Ub-specific processing proteases |
| R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks |
| R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) |
| R-HSA-5693607 | Processing of DNA double-strand break ends |
| R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere |
| R-HSA-68616 | Assembly of the ORC complex at the origin of replication |
| R-HSA-69473 | G2/M DNA damage checkpoint |
MSigDB gene sets: 176 (showing top):
REACTOME_MEIOTIC_RECOMBINATION, REACTOME_DNA_REPLICATION, REACTOME_SIGNALING_BY_NOTCH, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, CCAWYNNGAAR_UNKNOWN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_MEIOTIC_SYNAPSIS, REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT, GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA, GOBP_HUMORAL_IMMUNE_RESPONSE, CREB_Q3, REACTOME_DNA_REPAIR
GO Biological Process (0):
GO Molecular Function (3): DNA binding (GO:0003677), structural constituent of chromatin (GO:0030527), protein heterodimerization activity (GO:0046982)
GO Cellular Component (5): nucleosome (GO:0000786), nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829), chromosome (GO:0005694)
Reactome top-level categories
Rollup of top-12 pathways:
| Category | Pathways |
|---|---|
| Cellular Senescence | 3 |
| Depyrimidination | 2 |
| Depurination | 2 |
| Epigenetic regulation of gene expression | 2 |
| Chromatin modifying enzymes | 2 |
| Negative epigenetic regulation of rRNA expression | 2 |
| Positive epigenetic regulation of rRNA expression | 2 |
| Meiosis | 1 |
| Telomere Maintenance | 1 |
| Pre-NOTCH Expression and Processing | 1 |
| TCF dependent signaling in response to WNT | 1 |
| Mitotic Prophase | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromatin | 2 |
| cellular anatomical structure | 2 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| protein dimerization activity | 1 |
| protein-DNA complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
2310 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| H2BC26 | PLG | P00747 | 867 |
| H2BC26 | RNF20 | Q5VTR2 | 843 |
| H2BC26 | H3C1 | P02295 | 816 |
| H2BC26 | H3C14 | Q71DI3 | 815 |
| H2BC26 | H3-4 | Q16695 | 814 |
| H2BC26 | H3-7 | Q5TEC6 | 814 |
| H2BC26 | H3-3A | P06351 | 813 |
| H2BC26 | H3-5 | Q6NXT2 | 813 |
| H2BC26 | RNF40 | O75150 | 772 |
| H2BC26 | H4C16 | P02304 | 747 |
| H2BC26 | H2AC20 | Q16777 | 745 |
| H2BC26 | H2AC19 | P20670 | 745 |
| H2BC26 | H4C7 | Q99525 | 745 |
| H2BC26 | USP22 | Q9UPT9 | 728 |
| H2BC26 | DET1 | Q7L5Y6 | 727 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAP4K4 | STRN | psi-mi:“MI:0914”(association) | 0.530 |
| MED27 | POLR2D | psi-mi:“MI:0914”(association) | 0.530 |
| H2BC26 | PPM1G | psi-mi:“MI:0914”(association) | 0.530 |
| TNIP1 | COCH | psi-mi:“MI:0914”(association) | 0.350 |
| HAUS8 | ATP5PD | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| LIN28A | MEX3A | psi-mi:“MI:0914”(association) | 0.350 |
| PSMD3 | psi-mi:“MI:0914”(association) | 0.350 | |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| H1-0 | SMARCA5 | psi-mi:“MI:0914”(association) | 0.350 |
| H2BC21 | SMCHD1 | psi-mi:“MI:0914”(association) | 0.350 |
| NCK1 | SMARCA5 | psi-mi:“MI:0914”(association) | 0.350 |
| NECAP1 | SMARCA5 | psi-mi:“MI:0914”(association) | 0.350 |
| NUMA1 | SHANK3 | psi-mi:“MI:0914”(association) | 0.350 |
| PARP1 | KPNA3 | psi-mi:“MI:0914”(association) | 0.350 |
| PPM1G | SRP14 | psi-mi:“MI:0914”(association) | 0.350 |
| SSRP1 | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| SCRIB | CHD2 | psi-mi:“MI:0914”(association) | 0.350 |
| LZTS3 | SIPA1L1 | psi-mi:“MI:0914”(association) | 0.350 |
| H2AZ1 | PPM1G | psi-mi:“MI:0914”(association) | 0.350 |
| NS | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.350 |
| US11 | psi-mi:“MI:0914”(association) | 0.350 | |
| VP35 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (361): HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-RNA), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Affinity Capture-MS), HIST3H2BB (Synthetic Lethality)
ESM2 similar proteins: A0A2R8Y619, O97484, P02284, P02285, P02286, P02287, P02288, P04255, P04913, P07794, P07795, P0C1H4, P16888, P16889, P16890, P19374, P21897, P23527, P27326, P30757, P33778, P35067, P35068, P35069, P48557, P57053, P62807, P62808, P70696, P83863, Q00715, Q00729, Q16778, Q27894, Q32L48, Q5QNW6, Q5R893, Q5RCP8, Q64475, Q64478
Diamond homologs: A0A2R8Y619, A2WKT1, A2WKT4, A2WWU2, A2XF66, A2YWI3, A3AGM4, O22582, O60814, O65819, P02281, P02283, P02284, P02285, P02286, P02287, P02288, P02289, P02290, P04255, P06145, P06899, P06900, P07794, P07795, P0C1H3, P0C1H4, P0C1H5, P10853, P10854, P14001, P16888, P16889, P16890, P17271, P19374, P21897, P23527, P27326, P27807
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SLBP | “up-regulates quantity by expression” | H2BU1 | “translation regulation” |
| “MSL acetyltransferase” | “down-regulates activity” | H2BU1 | monoubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
264 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:228458507:G:GG | donor_gain | 0.9900 |
| 1:228458592:GGT:G | donor_gain | 0.9700 |
| 1:228458589:AAGG:A | donor_gain | 0.9600 |
| 1:228458587:TG:T | donor_gain | 0.9300 |
| 1:228458485:TCACC:T | donor_gain | 0.9200 |
| 1:228458593:GT:G | donor_gain | 0.9100 |
| 1:228458594:TT:T | donor_gain | 0.9100 |
| 1:228460340:A:G | acceptor_gain | 0.9000 |
| 1:228458594:T:G | donor_gain | 0.8900 |
| 1:228458492:G:GG | donor_gain | 0.8300 |
| 1:228458588:GAAG:G | donor_gain | 0.8300 |
| 1:228460011:G:GC | acceptor_gain | 0.8300 |
| 1:228458494:ACACC:A | donor_gain | 0.8200 |
| 1:228458491:A:AG | donor_gain | 0.8000 |
| 1:228458569:A:T | donor_gain | 0.7900 |
| 1:228458596:AT:A | donor_gain | 0.7800 |
| 1:228459877:A:AG | acceptor_gain | 0.7700 |
| 1:228459878:G:GG | acceptor_gain | 0.7700 |
| 1:228459441:T:TA | acceptor_gain | 0.7100 |
| 1:228458506:A:AG | donor_gain | 0.6900 |
| 1:228458590:AGGGT:A | donor_gain | 0.6600 |
| 1:228459608:C:G | donor_gain | 0.6500 |
| 1:228458512:G:T | donor_gain | 0.6400 |
| 1:228459485:GAGGA:G | acceptor_gain | 0.6400 |
| 1:228458511:G:GT | donor_gain | 0.6300 |
| 1:228459177:A:G | acceptor_gain | 0.6300 |
| 1:228459481:C:CA | acceptor_gain | 0.6300 |
| 1:228459482:CGGGA:C | acceptor_gain | 0.6300 |
| 1:228459483:GGGAG:G | acceptor_gain | 0.6300 |
| 1:228459484:GGAGG:G | acceptor_gain | 0.6300 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000238442 (1:228458768 T>A,C), RS1001050817 (1:228458095 C>A,G,T), RS1002053230 (1:228457187 CTGT>C), RS1002084351 (1:228457042 G>T), RS1003133451 (1:228457383 C>A,G,T), RS1003629686 (1:228456512 C>A,T), RS1003893672 (1:228457092 T>C,G), RS1003987150 (1:228456898 T>C), RS1005427562 (1:228458307 A>G), RS1007247054 (1:228458986 C>A,T), RS1007334703 (1:228458782 C>T), RS1008061056 (1:228457805 C>T), RS1008341408 (1:228457993 C>A,T), RS1009178635 (1:228456552 T>C), RS1009875224 (1:228456843 G>A)
Disease associations
OMIM: gene MIM:615046 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| decabromobiphenyl ether | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| nickel chloride | decreases acetylation, increases ubiquitination | 1 |
| ferrous chloride | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| lei gong teng | increases expression | 1 |
| epigallocatechin gallate | decreases expression | 1 |
| nickel acetate | decreases methylation, decreases ubiquitination, increases methylation, increases ubiquitination | 1 |
| abrine | increases expression | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Curcumin | increases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Nickel | decreases methylation, decreases ubiquitination, increases methylation, increases ubiquitination | 1 |
| Oxygen | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Lactic Acid | increases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.